Prothena reported 22.11 in PE Price to Earnings for its fiscal quarter ending in March of 2022.





Pe Change Date
Acadia Pharmaceuticals 11.33 1.25 Jun/2026
Agios Pharmaceuticals 3.56 0 Mar/2026
Akebia Therapeutics 1.63K 1.6K Dec/2025
ALKERMES 135.81 96.48 Jun/2026
Alnylam Pharmaceuticals 75.64 4.4 Jun/2026
Amgen 18.07 1.77 Jun/2026
Biogen 23.23 9.53 Jun/2026
BioMarin Pharmaceutical 21.07 5.79 Jun/2026
Exelixis 13.91 588.4 Mar/2026
Incyte 14.45 0.9 Jun/2026
Ionis Pharmaceuticals 396.15 79.28 Sep/2022
Neurocrine Biosciences 22.1 5.99 Jun/2026
Prothena 22.11 11.37 Mar/2022
Regeneron Pharmaceuticals 15.46 9.68 Jun/2026
Vertex Pharmaceuticals 28.05 2.22 Jun/2026